BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Marketing Authorization Application (MAA)
Orion Corporation Receives First Marketing Authorisations For Bufomix Easyhaler® Product 4/15/2014  More...
RedHill Biopharma Ltd. (RDHL) Announces Positive European Scientific Advice Meeting Regarding RHB-102 And Plans To Submit A European Marketing Application 4/7/2014  More...
Newron Pharmaceuticals (NWRN) Release: Safinamide Application For Authorization Submitted To Swissmedic 4/7/2014  More...
Keryx Biopharmaceuticals (KERX) Announces European Medicines Agency Validation Of Marketing Authorization Application For Zerenex™ 4/2/2014  More...
European Medicines Agency Validates Gilead Sciences, Inc. (GILD)’s Marketing Application For Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet For Genotype 1 Chronic Hepatitis C Infection 3/28/2014  More...
Shire Submits INTUNIV (Guanfacine Extended Release) Marketing Authorisation Application To European Medicines Agency 3/27/2014  More...
GlaxoSmithKline (GSK) Melanoma Drug Combination Faces Delay In Europe 3/26/2014  More...
Medivir AB (MVRBF): Simeprevir Receives Positive CHMP Opinion For The Treatment Of Adults With Chronic Hepatitis C In The European Union 3/21/2014  More...
Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT) Cancer Products Get Thumbs Up From EU Committee CHMP 3/21/2014  More...
Navidea Biopharmaceuticals (NAVB) Provides Update On European Marketing Authorization Application For Lymphoseek® 3/20/2014  More...
Keryx Biopharmaceuticals (KERX) Announces Submission Of A Marketing Authorization Application For Zerenex™ To The European Medicines Agency 3/10/2014  More...
Bayer HealthCare (BAY) And Regeneron Pharmaceuticals, Inc. (REGN) Announce Regulatory Submission Of EYLEA® (Aflibercept) Injection For The Treatment Of Diabetic Macular Edema In Japan 3/3/2014  More...
CHMP Issues Positive Opinion For Tablet Formulation Of Merck & Co., Inc. (MRK)’s NOXAFIL® (posaconazole) 2/28/2014  More...
Cubist Pharmaceuticals, Inc. (CBST) Announces European Medicines Agency Acceptance Of Tedizolid Marketing Authorization Application For Review 2/27/2014  More...
European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company (MDCO)'s Oritavancin 2/27/2014  More...
Janssen-Cilag International NV (JNJ) Release: VOKANAMET™ (Canagliflozin And Metformin Fixed Dose Combination) Receives Positive CHMP Opinion Recommending Approval In The European Union For The Treatment Of Adults With Type 2 Diabetes[1] 2/21/2014  More...
Teva Pharmaceutical Industries Limited (TEVA) Receives CHMP Positive Opinion For Duoresp® Spiromax® For The Treatment Of Patients Diagnosed With Asthma And COPD In Europe 2/21/2014  More...
GlaxoSmithKline (GSK)'s Anoro® (umeclidinium / vilanterol) Receives Positive Opinion From The CHMP In Europe For The Treatment Of COPD 2/20/2014  More...
BioMarin Pharmaceutical Inc. (BMRN) Receives Positive Opinion From The CHMP In The European Union For VIMIZIM™ (Elosulfase Alfa) For Morquio A Syndrome 2/20/2014  More...
Shire plc Submits Elvanse® (Lisdexamfetamine Dimesylate) For An Adult Licence In The UK, Denmark And Sweden 2/19/2014  More...
Dynavax Technologies Corporation (DVAX) Announces Withdrawal Of European Marketing Application For HEPLISAV™ 2/18/2014  More...
MSD Animal Health Receives Marketing Authorization From European Commission for BRAVECTO™ (fluralaner) 2/17/2014  More...
Vectura Group plc (VEC.L): Belgian Regulatory Authority Confirm Approval Of AirFluSal® Forspiro® 2/12/2014  More...
Arena Pharmaceuticals, Inc. (ARNA) Announces Filing For Marketing Authorization Of BELVIQ® (lorcaserin HCl) In Brazil 2/12/2014  More...
Vectura Group plc (VEC.L): Bulgarian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 2/4/2014  More...
XBiotech USA, Inc. And European Medicines Agency Agree On Phase III Registration Study For Treatment Of Colorectal Cancer 1/30/2014  More...
Vectura Group plc (VEC.L) Romanian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/29/2014  More...
Sinovac Biotech Ltd. (SVA) Files Clinical Trial Application With CFDA For Its Proprietary Vaccine Against Avian Influenza A(H7N9) Virus 1/29/2014  More...
Novartis AG (NVS)'s Potential Blockbuster Serelax Suffers Huge Setback 1/27/2014  More...
Endocyte, Inc. (ECYT) Provides Update On CHMP Review Of Pending EU Conditional Marketing Authorization Applications For Vintafolide And Etarfolatide 1/24/2014  More...
PTC Therapeutics, Inc. (PTCT) Slammed As EU Panel Recommends Against Muscular Disorder Drug 1/24/2014  More...
Teva Pharmaceutical Industries Limited (TEVA), Active Biotech AB (BTPC)'s NERVENTRA® Fails To Win European Medicines Agency Backing; Both Companies Remain Committed To The Drug 1/24/2014  More...
FINOX Biotech Release: CHMP Adopts Positive Opinion For BEMFOLA® For Treatment Of Infertility 1/23/2014  More...
Skyepharma PLC (SKYEF) Release: Positive Step Towards Marketing Authorisation For Flutiform® In Spain 1/22/2014  More...
Europe Approves Gilead Sciences, Inc. (GILD)'s Hot, New Hepatitis C Pill 1/20/2014  More...
Cytonet GmbH & Co. KG Submits European Approval Application For Liver Cell Therapy To Treat Urea Cycle Disorders In Children 1/16/2014  More...
European Medicines Agency Accepts Marketing Authorization Application For Biovest International, Inc.’s Cancer Vaccine For Treatment Of Non-Hodgkin’s Follicular Lymphoma 1/13/2014  More...
Bristol-Myers Squibb Company (BMY) Release: Daclatasvir Marketing Authorization Application For Treatment Of Chronic Hepatitis C Validated For Accelerated Regulatory Review By European Medicines Agency 1/8/2014  More...
Daiichi Sankyo, Inc. (4568.t) Submits Edoxaban Marketing Authorization Application To The EMA For Once-Daily Use For Stroke Prevention In Atrial Fibrillation And For The Treatment And Prevention Of Recurrence Of Venous Thromboembolism 1/7/2014  More...
European Medicines Agency Accepts Otsuka America Pharmaceutical, Inc.'s Marketing Authorisation Application (MAA) For Tolvaptan, An Investigational Compound For Autosomal Dominant Polycystic Kidney Disease (ADPKD) 12/27/2013  More...
European Medicines Agency Accepts Marketing Authorization Application For Durata Therapeutics, Inc.  (DRTX)'s Dalbavancin 12/23/2013  More...
European Medicines Agency Postpones Decision On Teva Pharmaceutical Industries Limited (TEVA)'s MS Pill Laquinimod 12/23/2013  More...
European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company (MDCO)'s Cangrelor 12/23/2013  More...
Active Biotech AB (BTPC) Release: Laquinimod CHMP/European Medicines Agency Opinion 12/20/2013  More...
Apricus Biosciences (APRI) Announces National Phase Approval For Erectile Dysfunction Cream - Vitaros® In France 12/20/2013  More...
Navidea Biopharmaceuticals (NAVB) Release: European Medicines Agency Continues Marketing Authorization Application (MAA) Review For Lymphoseek® 12/20/2013  More...
Recipharm AB Subsidiary Files Infectious Disease Drug Application In European Markets Drug Product Developed Through Partnership With Astimex Pharma AB 12/16/2013  More...
U.K. Cost Agency Seeks More Lemtrada Data From Sanofi (France) (SAN.PA) 12/5/2013  More...
Newron Pharmaceuticals (NWRN) Release: Safinamide Marketing Authorization Application (MAA) Submitted To The European Medicines Agency 12/5/2013  More...
Protectimmun Gets Positive Scientific Advice Response From European Medicines Agency For Innovative Allergy Prophylaxis 12/3/2013  More...
Durata Therapeutics, Inc.  (DRTX) Submits Marketing Authorization Application For Dalbavancin 12/3/2013  More...
CHMP Recommends Otsuka Pharmaceutical Co., Ltd.'s Deltyba™ (Delamanid) For EU Approval For Treatment Of Multidrug-Resistant Tuberculosis (MDR-TB) In Combination With Optimized Background Regimen (OBR) 11/25/2013  More...
Celgene International Sárl (CELG) Receives Positive CHMP Opinion For ABRAXANE® In Combination With Gemcitabine As Treatment For Patients With Metastatic Pancreatic Cancer 11/22/2013  More...
European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company (MDCO)'s Fibrocaps Hemostatic Agent 11/22/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: CHMP Determines Dimethyl Fumarate In TECFIDERA® To Be A New Active Substance In The European Union 11/22/2013  More...
European CHMP Adopts Positive Opinion for Gilead Sciences, Inc. (GILD)’ Sovaldi® For The Treatment Of Chronic Hepatitis C Infection 11/22/2013  More...
AstraZeneca PLC (AZN) And Bristol-Myers Squibb Company (BMY) Release: Xigduo™ (Dapagliflozin And Metformin Hydrochloride) Receives Positive CHMP Opinion In The European Union For The Treatment Of Type 2 Diabetes 11/22/2013  More...
ViiV Healthcare Release: Tivicay® (dolutegravir) Receives Positive CHMP Opinion In Europe For The Treatment Of HIV 11/22/2013  More...
Ariad Pharmaceuticals, Inc. (ARIA) Announces Positive Opinion By The European Medicines Agency On The Continued Availability Of Iclusig In Patients With Leukaemias 11/22/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces Positive Scientific Advice Meeting And European Marketing Application Strategy For RHB-103 (Migraine) 11/18/2013  More...
Boehringer Ingelheim Corporation Submits Applications In Europe To Extend The Indication For The Use Of Tiotropium Respimat® To The Treatment Of Asthma In Adults Aged 18 Years And Over 11/13/2013  More...
Bayer AG (BAYN.DE) Submits VEGF Trap-Eye (aflibercept solution for injection) for Treatment of Diabetic Macular Edema in the EU 11/7/2013  More...
Janssen-Cilag International NV (JNJ) Release: New Marketing Authorisation Application Submitted to European Medicines Agency for Ibrutinib for the Treatment of Two Forms of Blood Cancer 10/30/2013  More...
Actelion Ltd. (ALIOF.PK) and Lundbeck Inc. (LUN.CO) Get Positive CHMP Opinions 10/28/2013  More...
H. Lundbeck A/S (LUN.CO) Receives Positive Opinion for Approval of Brintellix (Vortioxetine) in the European Union 10/25/2013  More...
Gentium S.p.A. Receives Marketing Authorization From the European Commission (EC) for Defitelio® (Defibrotide) 10/22/2013  More...
Janssen-Cilag International NV (JNJ) Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir With Cobicistat 10/15/2013  More...
Boehringer Ingelheim Corporation Submits Nintedanib, a Novel Oncology Compound, for European Approval 10/14/2013  More...
Gentium S.p.A. Receives Positive Opinion From European Medicines Agency's COMP for Defibrotide for the Prevention of GvHD 10/11/2013  More...
GlaxoSmithKline (GSK) and Genmab A/S (GEN.CO) Announce European Submission to Regulatory Authorities for Arzerra® (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL) 10/4/2013  More...
Orexigen Therapeutics, Inc. (OREX) Submits Contrave Marketing Authorization Application to European Medicines Agency 10/3/2013  More...
Omeros Corporation (OMER) Release: U.S. and European Regulators Accept for Review OMS302 Marketing Applications 10/2/2013  More...
Nektar Therapeutics (CA) (NKTR) Reports that Partner AstraZeneca PLC (AZN) Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol 9/30/2013  More...
Ligand Pharmaceuticals Inc. (LGND) Partner GlaxoSmithKline (GSK) Receives Marketing Authorization From the European Commission (EC) for Additional Revolade™ (Eltrombopag) Indication as the First Approved Treatment for Chronic Hepatitis C-Associated Thrombocytopenia 9/24/2013  More...
Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Pharmaceutical Co. Ltd. (TKPYY) Receives European Marketing Authorization for VIPIDIA™ (alogliptin), VIPDOMET™ (alogliptin and metformin) and INCRESYNC™ (alogliptin and pioglitazone) 9/24/2013  More...
Xofigo® (radium Ra 223 dichloride) Injection Recommended for Approval in the European Union 9/20/2013  More...
Otsuka Pharmaceutical Co., Ltd. and Lundbeck Inc. (LUN.CO) Receive Positive CHMP Opinion in Europe for Abilify Maintena™, a Once-Monthly Injectable for Schizophrenia 9/20/2013  More...
Novo Nordisk A/S (NVO) Hemophilia-A Treatment Wins EU Panel Backing 9/20/2013  More...
Dendreon Corporation (DNDN) Announces Marketing Authorization for PROVENGE® in the European Union 9/17/2013  More...
Swissmedic Accepts for Review Basilea Pharmaceutica (BSLN.SW)'s Ceftobiprole Marketing Authorization Application for the Treatment of Pneumonia 9/16/2013  More...
Raptor Pharmaceutical Inc. (RPTP) Receives Marketing Authorization for PROCYSBI® in European Union 9/12/2013  More...
NanoViricides, Inc. (NNVC.PK) Reports That the DengueCide™ Orphan Drug Application has Been Submitted and Received by the European Medicines Agency 9/3/2013  More...
Apricus Biosciences (APRI) Receives National Phase Approvals for Vitaros® in Ireland and the Netherlands 8/15/2013  More...
Teva Pharmaceutical Industries Limited (TEVA) Receives European Marketing Authorization for Lonquex® (XM22 lipegfilgrastim) 8/8/2013  More...
Bavarian Nordic (BAVA.CO) Receives European Marketing Authorization for IMVANEX Smallpox Vaccine 8/7/2013  More...
Skyepharma PLC (SKYEF) Release: flutiform® Recommended for Approval in Japan 7/31/2013  More...
First in Class Once-Daily Dual Bronchodilator Ultibro® Breezhaler® (QVA149) Gains Positive CHMP Opinion for the Treatment of COPD 7/29/2013  More...
CHMP Confirms Prior Opinion Regarding Marketing Authorization in Europe for Pfizer Inc. (PFE)'s XELJANZ® (tofacitinib citrate) 7/26/2013  More...
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe 7/26/2013  More...
Merck & Co., Inc. (MRK) Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin 7/26/2013  More...
Otsuka Pharmaceutical Co., Ltd. Receives Opinion From CHMP on Delamanid 7/26/2013  More...
Ligand Pharmaceuticals Inc. (LGND) Partner GlaxoSmithKline (GSK) Receives Positive CHMP Opinion for REVOLADE™ in Thrombocytopenia Associated with Chronic Hepatitis C Infection 7/26/2013  More...
Boehringer Ingelheim Corporation's Afatinib Receives Positive CHMP Opinion for Patients With EGFR Mutation Positive Lung Cancer in European Union 7/26/2013  More...
Furiex Pharmaceuticals, Inc. (FURX) Confirms Takeda Pharmaceutical Co. Ltd. (TKPYY) Receives Positive CHMP Opinion for VIPIDIA™ (alogliptin) and Fixed-Dose Combinations VIPDOMET™ (alogliptin and metformin) and INCRESYNC™ (alogliptin and pioglitazone) 7/26/2013  More...
Gentium S.p.A. Receives Positive Opinion From European Medicines Agency's CHMP for Defitelio 7/26/2013  More...
Novartis AG (NVS) Vaccine Division Hit by Bexsero Setback 7/24/2013  More...
NanoViricides, Inc. (NNVC.PK) Receives Notification That Clinical Coordinators Have Been Appointed by the European Medicines Agency to Review the Company's Upcoming DengueCide Orphan Drug Designation Application 7/22/2013  More...
Biological E. Limited's Japanese Encephalitis Vaccine Prequalified by the World Health Organization 7/22/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: US and EU Regulatory Authorities Accept PLEGRIDY™ (peginterferon beta-1a) Marketing Applications for Review 7/19/2013  More...
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) Receives Positive Opinion From the Committee for Orphan Medicinal Products for Treatment of Neuromyelitis Optica (NMO) 7/16/2013  More...
Eli Lilly and Company (LLY) and Boehringer Ingelheim Corporation Announce Regulatory Submission for New Insulin Glargine Biosimilar Product 7/10/2013  More...
European Medicines Agency Approves Positive Opinion on Omeros Corporation (OMER)' Pediatric Investigation Plan for OMS302 7/2/2013  More...
Emergent BioSolutions (EBS) Receives Paul-Ehrlich-Institut Approval to Market BioThrax in Germany 7/1/2013  More...
First Copy of Johnson & Johnson (JNJ)'s $6 Billion Remicade Wins European Medicines Agency Backing 6/28/2013  More...
CHMP Gives a Positive Opinion for the Use of Janssen-Cilag International NV (JNJ)'s VELCADE® as Retreatment and for Frontline Induction Therapy Before Stem Cell Transplantation 6/28/2013  More...
Halozyme Therapeutics, Inc. (HALO) Announces Positive Opinion From CHMP on Roche (RHHBY)'s Herceptin SC for European Approval 6/28/2013  More...
Raptor Pharmaceutical Inc. (RPTP)'s PROCYSBI™ Receives Positive Recommendation From CHMP 6/28/2013  More...
Genzyme Corporation (GENZ) Receives Positive CHMP Opinion for LEMTRADA™ (alemtuzumab) in Europe 6/28/2013  More...
Dendreon Corporation (DNDN) Surges After Cancer Drug Gets European Backing, Stock Up +0.1701 (4.17%) @10:07 AM ET 6/28/2013  More...
Sanofi (France) (SAN.PA)'s MS Drugs Get Double Boost in Europe 6/28/2013  More...
Valneva Release: ACIP Unanimously Votes to Extend the Recommendations for Use of IXIARO® Vaccine 6/21/2013  More...
Immune Response BioPharma to Seek Approval of REMUNE With MCC of South Africa 6/18/2013  More...
Cangene Corporation (CC:CNJ) Withdraws MAA for Investigational Hemophilia Compound 6/14/2013  More...
Alimera Sciences (ALIM) Announces Issuance of a Positive Appraisal Recommendation on ILUVIEN® for Consultation in the United Kingdom 6/14/2013  More...
pSivida Corp (PSDV) Announces UK's National Institute for Clinical Excellence (NICE) Says Yes to ILUVIEN® in Some Patients With Diabetic Macular Edema in New Draft Guidance 6/13/2013  More...
ThromboGenics NV (TBGNF)' JETREA® Receives Positive Initial National Institute for Clinical Excellence (NICE) Recommendation for Vitreomacular Traction and Macular Hole 6/12/2013  More...
Gentium S.p.A. Provides Update on Re-Examination of Defibrotide MAA to EMA 6/4/2013  More...
Teva Pharmaceutical Industries Limited (TEVA)'s Lonquex®(XM22 lipegfilgrastim) Recommended for Approval in the EU for the Reduction of Chemotherapy-Induced Neutropenia (CIN) 6/3/2013  More...
European Medicines Agency Recommends Approval of Aegerion Pharmaceuticals, Inc. (AEGR)'s Pomalidomide for the Treatment of Multiple Myeloma 5/31/2013  More...
Bavarian Nordic (BAVA.CO)'s IMVANEX® Smallpox Vaccine Receives Positive Opinion From European Regulatory Authorities 5/31/2013  More...
BioPartners GmbH Release: Positive CHMP Opinion for Once-Weekly Somatropin Biopartners 5/31/2013  More...
Novo Nordisk A/S (NVO) Files for Regulatory Approval of IDegLira in the EU for the Treatment of Type 2 Diabetes 5/31/2013  More...
Oral Anti-Cancer Therapy Pomalidomide Celgene International Sárl (CELG) Receives Positive CHMP Opinion as Treatment for Patients With Relapsed and Refractory Multiple Myeloma 5/31/2013  More...
EU Agency Calls for Curbs on GlaxoSmithKline (GSK), Valeant Pharmaceuticals International (VRX) Epilepsy Drug 5/31/2013  More...
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) (AVEO) Drops as Astellas Pharma Inc. (YPH.BE) Will Not Seek Nod for Kidney Cancer Drug 5/28/2013  More...
Astellas Pharma Inc. (YPH.BE) and Medivation, Inc. (MDVN) Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan 5/24/2013  More...
European Medicines Agency Accepts Veloxis Pharmaceuticals A/S (VELO)' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients 5/22/2013  More...
European Medicines Agency Validates Gilead Sciences, Inc. (GILD)'s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C 5/22/2013  More...
Baxter International, Inc. (BAX) Receives Marketing Authorization for HyQvia in European Union 5/21/2013  More...
Arena Pharmaceuticals, Inc. (ARNA) Withdraws Diet Drug Application in Europe 5/3/2013  More...
Omeros Corporation (OMER) Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review 4/30/2013  More...
Veloxis Pharmaceuticals A/S (VELO) Announces Submission of Marketing Authorization Application (MAA) to European Medicines Agency (EMA) for LCP-Tacro™ for Treatment of Kidney Transplant Patients 4/29/2013  More...
Pfizer Inc. (PFE)'s Arthritis Drug Rejected by European Regulators 4/29/2013  More...
AVANIR Pharmaceuticals (AVNR) Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe 4/29/2013  More...
Astellas Pharma Inc. (YPH.BE), Medivation, Inc. (MDVN) Release: Positive CHMP Opinion for Xtandi ™ (Enzalutamide) in Advanced Prostate Cancer 4/26/2013  More...
VIVUS, Inc. (VVUS) Announces Positive Recommendation From CHMP Supporting Avanafil Approval in Europe 4/26/2013  More...
Celgene (CELG) Release: Oral Anti-Cancer Therapy REVLIMID® Receives Positive CHMP Opinion as Treatment for Patients With Form of Rare Blood Cancer Deletion 5Q Myelodysplastic Syndromes 4/26/2013  More...
Janssen Research & Development Release: INCIVO® Receives Positive Opinion From the Committee for Medicinal Products for Human Use (CHMP) for Twice Daily Dosing for Treatment of Genotype-1 Hepatitis C Virus 4/26/2013  More...
Curis, Inc. (CRIS) Announces Erivedge® Receives Positive CHMP Opinion for Conditional Approval in European Union 4/26/2013  More...
Medivir AB (MVIRb.F): Marketing Authorization Application for Simeprevir to the European Medicines Agency for the Treatment of Patients With Genotype 1 and Genotype 4 Hepatitis C is Now Filed 4/24/2013  More...
Arena Pharmaceuticals, Inc. (ARNA) Announces Eisai Inc. (ESALF.PK)'s Submission of BELVIQ® (lorcaserin HCl) Marketing Authorization Application in Mexico 4/1/2013  More...
Pfizer Inc. (PFE)'s BOSULIF® (bosutinib) Receives Conditional Marketing Authorization From the European Commission (EC) 3/28/2013  More...
European Medicines Agency Accepts MAA Submission of Shionogi, Inc.'s Ospemifene for the Treatment of VVA 3/27/2013  More...
European Medicines Agency Accepts Marketing Authorization Application for Boehringer Ingelheim Corporation and Eli Lilly and Company (LLY)'s Empagliflozin, an Investigational Type 2 Diabetes Treatment 3/26/2013  More...
Biogen Idec, Inc. (Massachusetts) (BIIB) Multiple Sclerosis Drug Wins EU Agency's Backing 3/25/2013  More...
European CHMP Adopts Positive Opinion for Gilead Sciences, Inc. (GILD)'s Stribild®, a Once-Daily, Integrase Inhibitor-Based, Single Tablet Regimen for the Treatment of HIV-1 Infection 3/22/2013  More...
Gentium S.p.A. Receives Negative Opinion From the CHMP on Defibrotide for the Treatment and Prevention of VOD 3/22/2013  More...
Sanofi (France) (SAN.PA) Gets EU Panel Backing for Multiple Sclerosis Pill Aubagio 3/22/2013  More...
Vanda Pharmaceuticals, Inc. (VNDA) Withdraws EU Filing for Schizophrenia Drug 3/15/2013  More...
Horizon Pharma, Inc. (HZNP) Receives Marketing Authorization for DUEXIS® From the United Kingdom Medicines and Healthcare Products Regulatory Agency 3/7/2013  More...
Takeda Pharmaceutical Co. Ltd. (TKPYY) Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the European Union 3/7/2013  More...
BioTie Therapies Corp.: Selincro (nalmefene) Receives European Marketing Authorization 2/28/2013  More...
Taiho Pharmaceutical Submits Application for Approval to Manufacture and Market Novel Antitumor Agent TAS-102 2/27/2013  More...
Medivir AB (MVIRb.F): Regulatory Application Has Now Been Filed for Simeprevir (TMC435) in Japan for the Treatment of Genotype 1 Hepatitis C Patients 2/22/2013  More...
Alexza Pharmaceuticals, Inc. (ALXA) Receives Marketing Authorization for ADASUVE® (Staccato® Loxapine) in the European Union 2/21/2013  More...
Epigenomics AG Receives Notification of Priority Review Status and Acceptance for Filing by FDA of PMA Application for Epi proColon® 2/21/2013  More...
Gentium S.p.A. Negative on Defibrotide 2/21/2013  More...
UCB, Inc. (UCBJF.PK) Announces Regulatory Filings for Cimzia® (Certolizumab Pegol) to Treat Psoriatic Arthritis and Axial Spondyloarthritis 2/20/2013  More...
Sanofi (France) (SAN.PA) Expects FDA Decision on Lemtrada in H2 2013 1/30/2013  More...
Santhera Pharmaceuticals AG (SANN.SW) Plunges on European Eye Drug Rejection 1/21/2013  More...
European Medicines Agency Backs Pfizer Inc. (PFE) Leukemia Drug 1/21/2013  More...
Gentium S.p.A. Provides an Update on Defibrotide MAA to European Medicines Agency 1/17/2013  More...
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) Announce Regulatory Submission for ANORO™ (UMEC/VI) in Europe 1/9/2013  More...
Otsuka Pharmaceutical Co., Ltd. and Lundbeck Inc. (LUN.CO) Initiate the Regulatory Process for Aripiprazole (Once-Monthly) Depot Formulation in Europe 12/27/2012  More...
Horizon Pharma, Inc. (HZNP) to Receive Approval of DUEXIS® From the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency 12/21/2012  More...
FINOX Biotech Release: r-FSH Biosimilar Submitted for European Medicines Agency Review 12/20/2012  More...
Shire plc ADHD Drug Elvanse Close to Europe Approval 12/19/2012  More...
Gentium S.p.A. Submit 2nd LoOIs Response to the European Medicines Agency's CHMP for Defibrotide MAA 12/18/2012  More...
Navidea Biopharmaceuticals (NEOP) Submits Lymphoseek Marketing Authorization Application to European Medicines Agency 12/18/2012  More...
Genzyme Corporation (GENZ)'s Mipomersen in Trouble in the Pipeline 12/17/2012  More...
H. Lundbeck A/S (LUN.CO) Receives Positive Opinion for Approval of Selincro (Nalmefene) in the European Union 12/14/2012  More...
Vanda Pharmaceuticals, Inc. (VNDA) Receives Negative Opinion From CHMP on Fanaptum™ for the Treatment of Schizophrenia 12/14/2012  More...
Alexza Pharmaceuticals, Inc. (ALXA) Release: the CHMP Delivers a Positive Opinion Recommending Grant of Marketing Authorization for ADASUVE® (Staccato® Loxapine) in the European Union 12/14/2012  More...
Halozyme Therapeutics, Inc. (HALO) Announced Roche (RHHBY) Filed a Marketing Authorization Application For Subcutaneous MabThera 12/10/2012  More...
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion 12/6/2012  More...
PTC Therapeutics, Inc. Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy 12/6/2012  More...
Novo Nordisk A/S (NVO): Ryzodeg® (insulin degludec/insulin aspart) Passed the Review by the First Committee on Drugs of Pharmaceutical Affairs in Japan 12/3/2012  More...
Merck & Co., Inc. (MRK) Withdraws MAA for Bone Cancer Treatment 11/30/2012  More...
Swedish Orphan Biovitrum Files to Expand Kineret® Label to Include CAPS 11/19/2012  More...
Alexza Pharmaceuticals, Inc. (ALXA) Receives Updated Day 180 List of Outstanding Issues for ADASUVE™ (Staccato® Loxapine) MAA 11/19/2012  More...
Zealand Pharma Announces That Once-Daily Lyxumia® 1 (lixisenatide) Has Received CHMP Positive Opinion for the Treatment of Adults With Type 2 Diabetes in the EU 11/16/2012  More...
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (France) (SAN.PA) Release: ZALTRAP® (ziv-aflibercept) Receives CHMP Positive Opinion in the European Union for Previously Treated Metastatic Colorectal Cancer 11/16/2012  More...
Novartis AG (NVS) Bexsero Meningitis Shot Wins EU Agency's Backing 11/16/2012  More...
Skuldtech Identifies New Predictive Markers for Pancreatic Cancer Survival Resulting From Its Proprietary Technology Platform 11/6/2012  More...
Ferring Pharmaceuticals' European Marketing Authorization Application for Controlled Release Misoprostol Vaginal Delivery System for the Induction of Labor Accepted for Review 11/5/2012  More...
Seattle Genetics, Inc. (SGEN) Gets Conditional OK for ADCETRIS® in EU; Triggers $25 Million Milestone Payment From Millennium: The Takeda Oncology Company 10/31/2012  More...
Pfizer Inc. (PFE)’s XALKORI® Receives Conditional Marketing Authorization From the European Commission (EC) for the Treatment of Adults With Previously Treated ALK-Positive Advanced Non-Small Cell Lung Cancer in the EU 10/24/2012  More...
Acusphere Inc. (ACUS) Announces Submission of Marketing Authorisation Application for Imagify™ in Europe and Start of Procedural Review 10/24/2012  More...
VIVUS, Inc. (VVUS) Obesity Drug Gets Expected European Rejection 10/19/2012  More...
EU Follows US Nod for Eli Lilly and Company (LLY)'s Brain Plaque Test 10/19/2012  More...
AB Science (AB.PA) Confirms the Filing for the Marketing Authorization Application to the European Medicines Agency of Masitinib in the Treatment of Pancreatic Cancer 10/16/2012  More...
Gentium S.p.A. Receives Second List of Outstanding Issues From the European Medicines Agency's CHMP for Defibrotide MAA 10/10/2012  More...
Basilea Pharmaceutica (BSLN.SW)'s European Marketing Authorization Application for ceftobiprole for the Treatment of Pneumonia Accepted for Review 10/5/2012  More...
AB Science (AB.PA) Release: European Medicines Agency Accepts Marketing Application for Masitinib in the Treatment of Gleevec® Resistant Gastro-Intestinal Stromal Tumor 10/4/2012  More...
Gentium S.p.A. Provides Update on the Review of Defibrotide Marketing Authorization Application 9/26/2012  More...
EU Agency Backs Roche (RHHBY)'s Avastin for Ovarian Cancer 9/24/2012  More...
VIVUS, Inc. (VVUS) Shares Feel the Pain: Blockbuster Diet Drug Likely Won't be Sold in Europe 9/24/2012  More...
Eli Lilly and Company (LLY) Gets Positive CHMP Opinion for Cialis 5 Mg to Treat BPH 9/21/2012  More...
New Bayer HealthCare (BAY), Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug Gets EU Agency Backing 9/21/2012  More...
Ironwood Pharmaceuticals Release: Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C 9/21/2012  More...





 

//-->